Welcome
We are delighted to invite you to the 2025 Asian Federation for Pharmaceutical Sciences (AFPS) Conference from 3 to 5 December 2025 in Sydney.
This conference will unite pharmaceutical scientists, researchers, and industry leaders from across Asia and beyond for three days of innovation, collaboration, and knowledge exchange.
‘One Health – Unifying Science, Innovation, and Humanity for a Sustainable Future’
Our conference theme reflects the critical intersection of health, environmental sustainability, and technological advancement. Through the central message of ‘Unifying Medicine, Nature, and Technology,’ we aim to foster meaningful dialogue and inspire solutions to today’s most pressing health challenges.
Why attend AFPS 2025?
- Access cutting-edge pharmaceutical research and insights from industry leaders, regulatory bodies, and academia through keynote talks, panel discussions, and poster sessions
- Experience live demonstrations of innovative technologies including AI-driven drug discovery, precision medicine tools, and digital therapeutics
- Enhance your expertise through hands-on workshops and specialised training in laboratory techniques, regulatory compliance, and data analytics
- Build valuable connections with international researchers, industry partners, and collaborators through mentoring sessions and themed networking events
- Contribute to discussions on critical topics like bio convergence, sustainable manufacturing, and the future of pharmacy education
- Participate in innovation challenges and collaborative problem-solving sessions focused on real-world pharmaceutical industry challenges
We look forward to welcoming you to Sydney for what promises to be an inspiring and rewarding event.
Prof Wojciech Chrzanowski
Co-chair
Prof Lee Yong Lim
Co-chair
Dr Philip Kwok
Co-chair
Prof Andrew McLachlan
Chief Patron
Invited speakers
Knowledge partners
RR MedScience
Industrial Partner
RR MedScience
RR MedSciences is a Sydney-based, clinical stage pharmaceutical company progressing therapeutic candidates for the treatment of pain and inflammatory conditions.
Taron Solutions
Industrial Partner
Taron Solutions
Taron Solutions is a rising global partnering and drug development accelerator specializing in biologic therapeutics. Over the years, we have successfully helped different products by leveraging our proprietary technology platforms as well as our team's combined 150+ years of international biotech experience in research, formulation, and process development to expedite regulatory approval pathway.
Craft Health
Industrial Partner
Craft Health
Craft Health is a Singapore-based healthcare and technology company providing automated platform solutions for personalised medicine and supplements. We provide a cutting-edge, innovative, and user-friendly platform that automates the production of personalized medicines, transforming healthcare and improving patient outcomes globally.
Established in 2019 by a team of pharmacists, our platform integrates patented hardware (no heat and UV), software, and standard premix materials. These solutions have been widely adopted across pharmacies, universities, and hospitals for research and development, just-in-time production of high-mix low-volume products, and educational programs.
Conference themes
- Advances in genomics, gene editing, and precision medicine.
- Ethical/legal considerations and regulatory challenges.
- Nuclear science in pharmaceutical and medical sciences
- Advancements in in vitro models, organoids, and computational simulations.
- 3Rs and cruelty-free research and development.
- Nanotechnology applications in drug formulation and targeted delivery.
- Extracellular vesicles as drug delivery vectors and adjuvants.
- Safety, efficacy, and scalability.
- Next-generation antimicrobials.
- Alternative therapies such as bacteriophage-based treatments, CRISPR-Cas antimicrobials, and microbiome-derived agents
- One health approaches to AMR
- Regulatory policies and stewardship programs.
- Innovations in 3D printing for the pharmaceutical industry.
- Regulatory considerations in 3D printed pharmaceuticals.
- Clinical applications and case studies of 3D printed drugs.
- AI for drug discovery, patient care, and supply chain optimization.
- Ethical implications and data privacy.
- Autonomous labs for sample processing, quality control, and inventory management.
- Safety protocols and cost-effectiveness.
- Collaboration between pharmaceutical companies and research institutions.
- Success stories and best practices.
- Hospital drug management, patient safety, and clinical pharmacy.
- Interdisciplinary teamwork.
- Medicine without Meds – transforming Patient Care with Digital Therapies
- Inaugural forum for an Asian Paediatric Formulation Initiative
- Development and evaluation of age-appropriate paediatric formulations
- Taste-masking strategies for paediatric formulations
- Evidence-based herbal medicine, traditional practices, and holistic approaches – indigenous medicines.
- Synergies with pharmaceuticals.
- Mechanopharmacology in drug discovery.
- Mechanobiology as a biomarker in drug development and testing.
Proudly sponsored by
